HOXB9 significantly enhanced angiogenesis, and bevacizumab administration significantly reduced angiogenesis of HUVECs co-cultured with HOXB9-overexpressing cancer cells (Figure 3b and Additional file 3: Figure S3e,f). The gene discussed is HOXB9; the disease is cancer.